Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

PRED-G

GENTAMICIN SULFATE; PREDNISOLONE ACETATE

Standard Dose
EQ 0.3% BASE;1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PRED-G is listed in Drugs@FDA under application 050586 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient GENTAMICIN SULFATE; PREDNISOLONE ACETATE Form and strength SUSPENSION/DROPS;OPHTHALMIC - EQ 0.3% BASE;1% Sponsor ALLERGAN Submission history Latest submission status date: 2018-06-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview PRED-G is listed in Drugs@FDA under application 050586 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient GENTAMICIN SULFATE; PREDNISOLONE ACETATE Form and strength SUSPENSION/DROPS;OPHTHALMIC - EQ 0.3% BASE;1% Sponsor ALLERGAN Submission history Latest submission status date: 2018-06-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.